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Abstract
First reported as a vasoactive peptide in the cardiovascular system, intermedin (IMD), also known as adrenomedullin 2
(ADM2), is a hormone with multiple potent roles, including its antioxidant action on the pulmonary, central nervous,
cardiovascular and renal systems. Though IMD may play certain roles in trophoblast cell invasion, early embryonic
development and cumulus cell-oocyte interaction, the role of IMD in the male reproductive system has yet to be
investigated. This paper reports our findings on the gene expression of IMD, its receptor components and its protein
localization in the testes. In a rat model, bacterial lippolysaccharide (LPS) induced atypical orchitis, and LPS treatment
upregulated the expression of IMD and one of its receptor component proteins, i.e. receptor activity modifying protein 2
(RAMP2). IMD decreased both plasma and testicular levels of reactive oxygen species (ROS) production, attenuated the
increase in the gene expression of the proinflammatory cytokines tumor necrosis factor alpha (TNFa), interleukin 6 (IL6) and
interleukin 1 beta (IL1b), rescued spermatogenesis, and prevented the decrease in plasma testosterone levels caused by LPS.
The restorative effect of IMD on steroidogenesis was also observed in hydrogen peroxide-treated rat primary Leydig cells
culture. Our results indicate IMD plays an important protective role in spermatogenesis and steroidogenesis, suggesting
therapeutic potential for IMD in pathological conditions such as orchitis.
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Introduction
Male factor infertility accounts for up to 50% of all cases of
infertility and affects one out of twenty men [1]. Evidence shows
oxidative stress is a common factor in testicular dysfunction,
inhibiting both Leydig cell steroidogenesis and spermatogenesis
[2,3]. Oxidative stress results when reactive oxygen species (ROS)
produced by the oxidation of lipids in membranes, amino acids in
proteins, and carbohydrates within nucleic acids are in excess.
Among the factors that cause oxidative stress in the testes are
radiation, cryptorchidism, testicular torsion and diabetes [2,3].
Oxidative stress from orchitis/testicular infection may have
transient or even permanent effects on male fertility [2,3]. In an
experimental model involving the intraperitoneal injection of
bacterial lipopolysaccharide (LPS), lipid peroxidation was induced
in the testes accompanied by a significant decrease in testosterone
production and disruption of spermatogenesis [4,5].
Intermedin (IMD), also known as adrenomedullin 2 (ADM2), is
a newly discovered hormone that belongs to the calcitonin, amylin,
calcitonin gene-related peptides (CGRP) and adrenomedullin
(ADM) peptide family. It was independently cloned by two groups
[6,7] and was shown to be expressed in the vasculature and a
variety of tissues in other organs including the stomach, kidney,
pituitary and placenta [6,7]. Like CGRP and ADM, IMD uses the
common receptor complexes which consist of calcitonin receptor-
like receptor (CLR) and one of the three receptor activity-
modifying proteins (RAMP1, RAMP2 and RAMP3) [6,7]. Some
of the reported actions of IMD are similar to those of ADM and
CGRP, and most of its roles are found in the cardiovascular
system. For example, intravenously IMD injection lowered blood
pressure [1,6,7,8] and intracerebroventricular injection of IMD
elevated blood pressure and heart rate [8].
IMD is noted for its protective role in tissue injury, such as
injuries to the central nervous, pulmonary, cardiovascular and
renal systems. IMD has been shown to protect rat cerebral
endothelial cells from oxidative damage in vitro [9] and attenuate
ventilator-induced lung injury in mice [10]. The increase in
myocardial oxidative stress was accompanied by a robust
augmentation of IMD expression in hypertrophied left ventricular
cardiomyocytes of spontaneously hypertensive rats (SHRs), com-
pared with normotensive Wistar–Kyoto rats [11]. IMD attenuated
oxidative stress injuries in the myocardium in a rat ischemia/
reperfusion model [12] and also in the blood vessels and kidneys of
DOCA-salt hypertensive rats [13].
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The expression of IMD has been reported in trophoblast cells in
human placenta [14,15]. The antagonism of IMD function in
pregnant rats demonstrated the important role of IMD during
implantation and early embryonic development [16], which was
further supported by the association of lower expression of IMD in
serum, villi and decidua with first-trimester spontaneous abortion
in patients [17]. Recently, IMD produced by the oocyte has
proven to be important for the regulation of cell interactions in
cumulus cell-enclosed oocyte complexes partly through its
suppressive action on cumulus cell apoptosis [18]. In contrast to
the research on the effects of IMD in the female reproductive
system, no biological function of IMD in the testes has been
reported.
All in all, it would be interesting to know whether or not IMD
and its receptors are expressed in the testes and whether it plays a
similar protective role in testicular oxidative stress. This study was
undertaken to investigate the possible expression of IMD in the
testes and its potential roles in testicular oxidative stress in a rat
model of LPS-induced atypical orchitis.
Materials and Methods
Ethics Statement
Normal human testes paraffin sections were purchased from
Pantomics (Pantomics, CA, USA: cat.no.TES01). Three-month-
old Balb/c mice and Sprague-Dawley rats were obtained from the
Laboratory Animal Center, Institutes of Biomedicine and Health,
Chinese Academy of Sciences, China. The animals were housed at
a constant temperature and humidity, with a 12-hour light-dark
cycle. Chow and water were available ad libitum. All procedures
related to animal usage were approved by the Committee on the
Use of Live Animals for Teaching and Research, Shenzhen
Institutes of Advanced Technology, Chinese Academy of Sciences
(Permit Number: SIAT-IRB-120223-A0009).
IMD Tissue Extraction and Measurement by
Radioimmunoassay (RIA)
Tissues, including the testes, epididymis, vas deferens, seminal
vesicle, coagulating gland and prostate were harvested from three-
month-old rats immediately after decapitation. Tissues were
homogenized in 2N ice-cold acetic acid and then boiled for
10 min. A 50 ml aliquot was taken for Bio-Rad protein assay (Bio-
Rad Laboratories, CA, USA: cat.no.500-0201EDU). The remain-
ing homogenates were centrifuged at 18, 600 g for 20 min at 4uC.
The supernatants were lyophilized and reconstituted in 1 X RIA
assay buffer. IMD peptide concentrations were measured in
duplicate using an Intermedin (Rat) - RIA Kit (Phoenix
Pharmaceuticals, CA, USA: cat.no.RK-010-52). The minimum
detectable concentration was 76 pg/ml and the range was 20–2,
560 pg/ml.
LPS and/or IMD Treatment and Tissue Collection
The rats were divided into three groups. While under
anesthesia, one group were intraperitoneally injected with saline
(0.2 ml/rat) only, one group with saline containing 4 mg/kg body
weight (BW) LPS (E.coli serotype 026:B6 from Sigma, MO, USA:
cat.no.L8274) and the third group with 4 mg/kg BW LPS
injection, followed by right femoral vein infusion of 10 nmol/kg
BW of rat IMD (Scipeptide, Shanghai, China: cat.no.P011090601)
for 10 min. At 6 h, 12 h and 72 h after LPS injection, 6–7 rats
from each group were weighed and decapitated. Blood was
collected and centrifuged at 1, 200 g for 10 min. The plasma was
measured for testosterone by RIA and its lipid peroxidation level
assessed by TBARS assay. One testis from each rat was
decapsulated and stored at -80uC for further analysis of gene
expression or testicular lipid peroxidation. The other testis was
fixed in 4% formaldehyde together with its epididymis for
histological studies.
Primary Leydig Cell Culture
Leydig cells were isolated from testes of 3-month-old male rats
and were cultured for 2 days as described previously with some
modifications [19]. Five rats were killed by decapitation. The testes
were excised rapidly and washed twice in 16 PBS. The
decapsulated testes were digested for 15 min in a shaking water-
bath at 80 cycles/min at 34uC in a flask containing DMEM/F12-
0.1% BSA (Sigma, MO, USA: cat.no.A7906) supplemented with
0.5 mg/ml collagenase (Sigma, MO, USA: cat.no.C0130) and
0.25 mg/ml soybean trypsin inhibitor (Sigma, MO, USA:
cat.no.T6522). Ice-cold medium was added to the flask to stop
the digestion. The suspension was allowed to settle for 5 min, and
the supernatant containing Leydig cells was filtered through cell
strainers (70 mm nylon, Falcon BD Biosciences, Germany:
cat.no.352350). The tubules were dispersed in another 50 ml
medium, and the supernatant was pooled and centrifuged. The
Leydig cells were separated by discontinuous Percoll (Amersham
Biosciences, Uppsala, Sweden: cat.no.17-5445-01) gradients (with
six density fractions ranging from 1.030 to 1.096 g/ml). Leydig
cells located at the boundary between fractions of 1.070 and
1.096 g/ml densities were collected and washed twice with ice-
cold DMEM/F12-0.1%BSA medium. The collected Leydig cells
were seeded in a NUNC 24-multiwell plate (NUNC, Roskilde,
Denmark: cat.no.142475). The cells were pre-incubated in
DMEM/F12-0.1%BSA at 34uC in a humidified atmosphere of
5% CO2/95% air. After 24 h incubation, the cell purity was
determined by 3b-hydroxysteroid dehydrogenase (3b-HSD) stain-
ing. The Leydig cells were treated for 24 h with 250 mM H2O2,
100 nM rat IMD or a combination of H2O2 and IMD or culture
media only. The media were collected for testosterone measure-
ment by RIA.
RNA Analysis by QPCR
The total RNA of the tissues and cells was extracted using
TRIZOL reagent (Invitrogen Life Technologies; cat.no. 15596-
018) and subjected to QPCR analysis. RNA samples (1 mg) were
reverse transcribed into cDNA according to the manufacturer’s
instructions (Bio-Rad Laboratories, CA, USA: cat.no.170-8890).
The PCR reaction mixtures contained 10 ml SYBR Premix Ex
TaqTM II (Takara, Japan: cat.no.DRR820), 500 nM of each
primer, 1 ml template cDNA, and DNase-free water to a final
volume of 20 ml. Cycle conditions were 95uC for 10 sec, followed
by 45 cycles of 95uC for 5 sec, 60uC for 30 sec, and 72uC for
30 sec. The reaction was completed with a dissociation step for
melting point analysis from 50uC to 95uC (in increments of 0.5uC
for 10 sec each). The primers were designed on the basis of the
published sequences of IMD (GCTGATGGTCACGGTAAC,
forward; CGCTGGAAGGAATCTTGG, reverse;
NM_201426.1), CLR (CCAAACAGACT TGGGAGTCAC-
TAGG, forward; GCTGTCTTCTCTTTCTCATGCGTGC,
reverse; NM_012717.1); RAMP1 (CACTCACTGCAC-
CAAACTCGTG, forward; CAGTCATGAGCAGTGT-
GACCGTAA, reverse; NM_031645.1); RAMP2 (AGGTATTA-
CAGCAACCTGCGGT, forward;
ACATCCTCTGGGGGATCGGAGA, reverse; NM_031646.1);
RAMP3 (ACCTGTCGGAGTTCATCGTG, forward; ACTT-
CATCCGGGGGGTCTTC, reverse; NM_020100.2) and tumor
necrosis factor alpha (TNFa) (AAATGGGCTCCCTCTCAT-
CAGTTC, forward; TCTGCTTGGTGGTTTG CTACGAC,
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reverse; NM_012675.3), interleukin 6 (IL6) (TCCTACCC-
CAACTTCCAATG CTC, forward;
TTGGATGGTCTTGGTCCTTAGCC, reverse;
NM_012589.1), interleukin 1 beta (IL1b) (CATTGTGGCTGTG-
GAGAAG, forward; ATCATCCCACGAGTCACAGA, reverse;
NM_031512.2), and beta-actin (GGAAATCGTGCGTGA-
CATTA, forward; AGGAAGGAAGGCTGGAAGAG, reverse;
NM_031144.3) for rats. The relative gene expression levels were
normalized to beta-actin using the DDCT method, where CT was
the cycle threshold. Melt curve analysis for each primer set
revealed only one peak for each product.
Histological Studies and Immunocytochemistry
The testes and epididymis were fixed and processed for
embedding in paraffin, sectioned (5 mm), and stained for
histological analysis by hematoxylin and eosin. Immunohisto-
chemistry of the testes was performed on 5 mm sections of paraffin-
embedded tissues with a peroxidase-labeling kit (Vector Labora-
tories, CA, USA: cat.no.PI-9500) using a rabbit anti-rat interme-
din antibody (Phoenix Pharmaceuticals, CA, USA: cat.no.H-010-
52). Staining was visualized using a DAB substrate kit for
peroxidase (Vector Laboratories, CA, USA: cat.no.SK-4105)
counterstained with hematoxylin. The primary antibody was
omitted from control sections to check for nonspecific staining.
Testosterone Measurement by RIA
The testosterone levels in the plasma and culture media were
measured using a commercial Iodine [125I] Radioimmunoassay Kit
(Lareneen, Guangzhou, China: cat.no.S-004). The sensitivity of
the testosterone RIA assay was 0.2 ng/dL, and the intra-assay and
inter-assay errors were less than 10% and 15% respectively.
Lipid Peroxidation Assessment by TBARS Assay
The levels of lipid peroxidation in the plasma and testes
homogenate were measured as TBARS using an oxiSelect TBARS
assay kit (MDA Quantitation, Cell Biolabs, CA, USA: cat.no.STA-
330). Plasma samples were assayed directly using the kit. The testes
were first homogenized on ice at 100 mg/ml in PBS containing
1X butylated hydroxytoluene (BHT) provided in the kit and then
centrifuged at 10, 000 g for 5 min to collect the supernatant. The
TBARS assay was used on 100 ul, while another 100 ul was
measured for protein normalization (Bio-Rad Laboratories, CA,
USA: cat.no.500-0201EDU).
Statistical Analysis
All data were expressed as mean 6 SEM, and statistical
significance was assessed by one-way ANOVA followed by
Student–Newmann–Keuls test or Student t-test. Statistical signif-
icance was taken at the P,0.05 level.
Results
The Expression of IMD and its Receptor Components in
Human and Rodent Testes
QPCR analysis showed the gene expression of IMD and its
receptor components in male reproductive system of rats,
including the testes (FIG.1). Compared with seminal vehicles
and coagulating glands, the gene expression of IMD is relatively
low, while those of CLR and RAMP2 are relatively high in the
testes. The epididymis also showed a relatively high expression
level of RAMP2 and RAMP3. Immunohistochemistry localized
IMD in human, mouse and rat testes, both in the interstitial
Leydig cells and to a lesser extent in the seminiferous tubules,
including the tails of the spermatids (FIG.2). RIA analysis showed
that the testes had the highest level of IMD peptide
(113.1619.5 fmol/mg protein) in rats compared with those in
the accessory sex glands (Table 1). The high level of IMD and the
expression of its receptor components in the testes imply a
potentially important biological role.
Effects of IMD on LPS-induced Changes in Body Weight,
Plasma Testosterone Levels in Vivo and H2O2-induced
Change in Testosterone Production in Vitro
Compared with saline control, the body weight (BW) of LPS-
treated animals decreased at 6 h, 12 h and 72 h after LPS
injection. Cotreatment of IMD with LPS attenuated this decrease
in BW at 12 h and 72 h after treatment (FIG.3A). LPS also
induced a dramatic drop in plasma testosterone levels, which
persisted at 6 h, 12 h and 72 h after LPS treatment. IMD
cotreatment restored the LPS-suppressed testosterone levels back
to normal at 72 h (FIG.3B). The same effect of IMD on H2O2-
suppressed testosterone production in vitro was demonstrated in
primary Leydig cell cultures from rats (FIG.3C), though IMD
showed no effect on basal testosterone production (data now
shown).
Effect of IMD on LPS-induced Histological Changes in the
Testes
Histological examination of the testes and epididymis sections
revealed the disruptive effects of LPS on testicular morphology.
Compared with saline control, LPS-treated testes at 6 h after
injection showed an accumulation of immature germ cells in the
lumen (lumina) of some seminiferous tubules. Such an accumu-
lation was not observed in the IMD-cotreated testes (FIG.4A).
LPS-treated testes 72 h after injection showed an increase in inter-
cellular gaps, due to the disruption of cell-cell contact or loss of
cells in the seminiferous epithelium (FIG.4B), accompanied by
large numbers of round, immature germ cells in the epididymal
lumen (FIG.4C); this was not found with the IMD cotreatment
(FIG.4B&C). Counting five random fields under 20X magnifica-
tion showed a significant increase in the number of sloughing
immature germ cells in LPS-treated epididymis compared with
saline control, and this increase was eliminated with IMD
cotreatment (FIG.4D).
Effect of IMD on LPS-induced Plasma Lipid Peroxidation
and Testicular Lipid Peroxidation
Lipid peroxidation levels in plasma and testicular tissues were
evaluated by TBARS assay through MDA quantification.
Peroxidation of unsaturated fatty acids in membrane phospholip-
ids is one of the multiple cytotoxic effects of oxidative stress, and
lipid peroxidation is the hallmark of toxicant-induced cellular
damage. LPS-treatment induced a more than 3-fold increase in
plasma lipid peroxidation levels and a similar, but smaller, increase
in testicular lipid peroxidation levels at 6 h after LPS treatment.
Both were attenuated by IMD cotreatment (FIG.5). The lipid
peroxidation levels, in both the plasma and testes, returned to
basal levels at 12 h and 72 h after LPS treatment (FIG.5).
Effect of IMD on LPS-induced Proinflammatory Cytokines
Expression in the Testes
LPS-treatment induced a dramatic increase in the testicular
proinflammatory cytokine TNFa, IL6 and IL1b expression, which
peaked at 6 h after treatment, and maintained a relatively high
level in both the LPS alone and IMD cotreatment groups at 12 h
and 72 h after LPS treatment compared with the saline control.
IMD Attenuates LPS-Induced Testicular Damages
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Cotreatment of IMD attenuated but did not eliminate TNFa
induction at 6 h, IL6 at 12 h and IL1b at 72 h after treatment
(FIG.6).
Effect of LPS on Testicular Expression of IMD and its
Receptor Components
The effect of LPS-treatment on IMD and its receptor
components’ testicular gene expression was evaluated by QPCR.
LPS treatment resulted in an increase in testicular IMD and
RAMP2 expression. The IMD expression level increased at 72 h
after LPS treatment while the RAMP2 expression level increased
at 12 h and 72 h after LPS treatment (FIG.7).
Discussion
High expression levels of both IMD and its receptor complex
components CLR/RAMPs were detected in rat testes in our study
(FIG.1). The expression of CLR/RAMPs was previously reported
in rat testes [18]. IMD RNA was not detected by Takei et al. in
mouse testes [7]. The discrepancy may be due to differences in
species (rat vs. mouse) and detection methods (QPCR vs. RT-
PCR). We are the first group to report the protein localization of
IMD (FIG.2) and its high levels in the testes (Table 1). The high
level of IMD and the presence of its receptor components in the
testes are consistent with its biological role(s) of protecting against
the impairment of steroidogenesis and spermatogenesis by LPS
treatment.
Testes can be compartmentalized functionally and anatomically
into the gamete and endocrine compartments where spermato-
genesis and steroidogenesis take place respectively. Consistent with
the results from previous studies, LPS treatment in this study
compromised testicular function at multiple levels, including
decreased steroidogenesis and impaired spermatogenesis [4,20].
IMD showed protective effects against both types of LPS-induced
damage. IMD treatment did not prevent the decrease in
testosterone production at 6 h and 12 h after LPS treatment,
although it eliminated the increase in ROS levels at 6 h after LPS
injection, and greatly attenuated the increase in the gene
expression of TNFa at 6 h, of IL6 at 12 h and IL1b at 72 h
after LPS injection (FIG.3, FIG.6.). It is important to note here
that infusion of IMD for 10 min was sufficient to prevent the
increase in ROS and cytokine expression 6 h to 72 h after LPS
injection, and restored the plasma testosterone level to normal at
72 h after LPS injection. The restorative effect of IMD on LPS-
suppressed testosterone secretion might be due to direct effects on
both the testicular ROS production and the proinflammatory
cytokines (TNFa, IL6 and IL1b) production. ROS are rapidly
released from the activated immune system [21] after LPS
Figure 1. Gene expression of IMD and its receptor components in rat male reproductive systems. The relative gene expression of
intermedin (IMD) and its receptors components CLR, RAMP1, RAMP2 and RAMP3 in adult rat male reproductive systems including testes, epididymis,
vas deferens, seminal vesicles, coagulating glands and prostate was analyzed by QPCR. Beta-actin served as the reference gene; all data were
expressed as mean 6 SEM; n = 5–6.
doi:10.1371/journal.pone.0065278.g001
IMD Attenuates LPS-Induced Testicular Damages
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e65278
injection, probably from the interstitial macrophages [22] and
spermatozoa [23]. The suppression of ROS by IMD treatment to
basal level at 6 h was not accompanied by the restoration of
plasma testosterone levels, which indicates that ROS suppression
alone could not reverse the LPS-suppressed testosterone produc-
tion in vivo (FIG.5). However, the in vitro finding of a role of IMD
in preventing the decrease in testosterone production by hydrogen
peroxide (an ROS) in primary Leydig cells is in agreement with
the in vivo data on the IMD effect on ROS (FIG.3C). The
prolonged suppression of testosterone levels up to 12 h post-
treatment might be due to the proinflammatory cytokines TNFa
and IL6 since their expression levels were only attenuated and not
eliminated at 6 h (TNFa) and 12 h (IL6) after LPS treatment while
they were restored at 72 h (TNFa, IL6 and IL1b) after IMD co-
Figure 2. Immunolocalization of IMD in human, mouse and rat testis sections. Intermedin positive immunostaining was located to both in
the interstitial Leydig cells and to a lesser extent in the seminiferous tubules, including the tails of the spermatids. Representative sections of n = 4
stain with similar results; negative control omitting primary antibody for each section was presented in parallel at right panel; scale bars, 0.1 mm and
0.05 mm as indicated in each picture.
doi:10.1371/journal.pone.0065278.g002
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treatment. Previous reports showed in testis, the proinflammatory
cytokines including IL1b from interstitial macrophages [24], IL6
from interstitial macrophages [25], Leydig cells [26], Sertoli cells
[27] and TNFa from macrophages [28] and spermatocytes [29] all
inhibited testosterone production by Leydig cells [30].
On the other hand, IMD co-treatment did restore the impaired
spermatogenesis, with effects including the accumulation of
immature germ cells in the seminiferous tubule lumen at 6 h
post-LPS treatment, and the increased inter-cellular gaps in the
seminiferous epithelium and accumulation of round immature
germ cells in the epididymal lumen at 72 h post-LPS treatment
(FIG.4). IMD prevented the accumulation of immature germ cells
in the seminiferous tubule at 6 h post treatment, before the
attenuation of IMD on IL6 and IL1b expression. Presumably this
was due to the effect of IMD in preventing the increase in ROS
and was also independent of the decrease in testosterone
production although testosterone is known to play a very
important role in spermatogenesis.
The increased gene expression of IMD and RAMP2 (FIG.7) in
the testes after LPS treatment implies that IMD may act partially
in an autocrine or paracrine manner in the testes via binding to
the CLR/RAMP2 receptor system. Although the study on the
effect of LPS on the gene expression of IMD indicates that there
was a significant increase in IMD expression at 72 h after LPS
injection, the return of the plasma testosterone levels to normal
was not observed in the LPS treated group without exogenous
IMD co-treatment, suggesting this restoration at 72 h was not
solely due to the increase in testicular IMD expression.
The localization of immunoreactive IMD both in the interstitial
Leydig cells and in the spermatids inside the seminiferous tubules
was consistent with its known effects of targeting different cell types
in the testes (FIG.2). At present we know that the action of IMD is
mediated by CLR/RAMPs, in which RAMP1–3 acts as molecular
chaperones for transporting CLR from the endoplasmic reticulum
and Golgi apparatus to the cell surface [31]. The downstream
signaling pathways of CLR include the PI3K/Akt, cAMP/PKA
and MAPK signaling cascade [31]. To fully understand the
Table 1. IMD levels in rat male reproductive tract.







Figure 3. Effects of IMD on the LPS-induced changes in body weight, plasma testosterone levels in vivo and H2O2-induced change
in testosterone production in vitro. IMD cotreatment restored the decreased body weight (A), plasma testosterone levels (B) 72 h after LPS
treatment. IMD also rescued the H2O2 suppressed testosterone production from primary Leydig cells (C). All data were expressed as mean 6 SEM; *
P,0.05 by one-way ANOVA followed by Student–Newmann–Keuls test for (A) and (B); * P,0.05 by Student t-test for (C); n = 5–7.
doi:10.1371/journal.pone.0065278.g003
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detailed mechanism, further investigation is required on which
specific IMD receptor(s) and downstream signaling pathways IMD
functions through.
Altogether IMD, through the suppression of ROS production
and the proinflammatory cytokines expression, attenuated the
LPS-induced suppression of steroidogenesis in Leydig cells and the
Figure 4. Histological examination of the rat testes and epididymis after LPS treatment or LPS and IMD cotreatment compared with
saline control. (A) LPS-treated testes 6 h after injection, showing accumulation of immature germ cells (indicated by arrows) in the seminiferous
tubule lumen, which was not observed in the IMD-cotreated testis. (B) LPS-treated testes 72 h after injection, showing increased inter cellular gaps
(indicated by arrows) due to disruption of cell-cell contract and/or loss of cells in the seminiferous epithelium, which was not observed in the IMD-
cotreated testis. (C) LPS-treated epididymis 72 h after injection, showing large numbers of round immature germ cells (indicated by arrowheads) in
the epididymal lumen, which was not observed in the IMD-cotreated epididymis. (D) Quantitive presentation of the detached round immature germ
cells in the epididymal lumen by counting five random fields under 20X magnification. Data were expressed as mean 6 SEM; * P,0.05 by Student t-
test for (D); For (A), (B), and (C), representative sections of n = 5–7 rats with similar results.
doi:10.1371/journal.pone.0065278.g004
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Figure 5. IMD cotreatment suppressed the LPS-induced lipid peroxidation in rats. Lipid peroxidation was assessed by TBARS assay (MDA
quantitation) in plasma and in the testis 6 h, 12 h, 72 h after LPS treatment or LPS and IMD cotreatment compared with saline control. (A)
Cotreatment of IMD suppressed the LPS-induced increase in circulating lipid peroxidation levels 6 h after treatment. (B) Cotreatment of IMD
suppressed the LPS-induced increase in testicular lipid peroxidation levels 6 h after treatment. All data were expressed as mean 6 SEM; * P,0.05 by
one-way ANOVA followed by Student–Newmann–Keuls test; n = 5–7.
doi:10.1371/journal.pone.0065278.g005
Figure 6. Effects of IMD cotreatment on the LPS-induced gene expression of proinflammatory cytokines in rat testis. The relative
gene expression of TNFa, IL6 and IL1b in the testes 6 h, 12 h, 72 h after LPS treatment or LPS and IMD cotreatment compared with saline control was
analyzed by QPCR. (A) Cotreatment of IMD suppressed the LPS-induced increase in TNFa expression at 6 h after treatment. (B) Cotreatment of IMD
suppressed the LPS-induced increase in IL6 expression at 12 h after treatment. (C) Cotreatment of IMD suppressed the LPS-induced increase in IL1b
expression at 72 h after treatment. Beta-actin served as the reference gene; all data were expressed as mean 6 SEM; * P,0.05 by one-way ANOVA
followed by Student–Newmann–Keuls test; n = 5–7.
doi:10.1371/journal.pone.0065278.g006
IMD Attenuates LPS-Induced Testicular Damages
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damage to spermatogenesis. Our results suggest important
pathophysiological roles for IMD in the testes for its intrinsic
antioxidant capacity and regulation of proinflammatory cytokines
production, implying the therapeutic potential of IMD in
pathological conditions such as orchitis.
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